Aptevo Therapeutics (APVO) Live Share Price, Invest From India

Aptevo Therapeutics Stock Performance

as on August 31, 2026 at 2:16 pm IST

Day's Low
Day's High
$2.31
Day's Price Range
$2.46
$2.37
2.53%
Downside
3.80%
Upside
52 Week's Low
52 Week's High
$2.30
52-Week Price Range
$48.78
$2.37
2.93%
Downside
1958.23%
Upside

Aptevo Therapeutics share price movements today

Previous Close: $2.42
Open: $2.46
Volume: 319.4K
Market Cap: $4.3M
Day's Low - High: $2.31 - $2.46
52 Week Low - High: $2.30 - $48.78

Aptevo Therapeutics Historical Returns

1 Month Return: -42.46 %
3 Month Return: -51.83 %
1 Year Return: -91.99 %
3 Year Return: -100 %
5 Year Return: -100 %

Aptevo Therapeutics Stock Fundamentals & Key Indicators

Check Aptevo Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3M

EPS (TTM)

-16.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.01

Industry PE ratio

-1.6496124031007753

PEG Ratio

EBITDA

-26.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-420.34%

Aptevo Therapeutics Stock Valuation

Track how Aptevo Therapeutics P/E has moved over time to understand its valuation trends.

Aptevo Therapeutics in the last 5 years

Overview
Trends

Lowest (-3.76x)

September 30, 2021

Industry (-1.65x)

August 31, 2026

Today (0.01x)

August 31, 2026

Highest (-0.01x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.01x

Aptevo Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aptevo Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Aptevo Therapeutics	BUY	$4.3M	-100%	0.01	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$137.2B	170.45%	31.92	86.04%	NA
Moderna	BUY	$55.1B	-63.37%	-7.98	-12.57%	NA
Regeneron	BUY	$85.8B	17.94%	19.9	84.86%	0.44%

Stock Returns calculator for Aptevo Therapeutics Stock including INR - Dollar returns

The Aptevo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Aptevo Therapeutics investment value today

Current value as on today

₹8,702

Returns

-₹91,298

(-91.3%)

Returns from Aptevo Therapeutics Stock

-₹91,972 (-91.97%)

Dollar Impact

₹673 (+0.67%)

Analyst Recommendation on Aptevo Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Aptevo Therapeutics. Average target price of $25.5

Aptevo Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Aptevo Therapeutics.

What analysts predicted

90.71%UPSIDE

Target Price

$25.5

Current Price

$2.37

Analyzed by

1 Analysts

Target

$25.50

Aptevo Therapeutics target price $25.5, a slight upside of 90.71% compared to current price of $2.37. According to 1 analysts rating.

Indian Investors' Interest in Aptevo Therapeutics Stock

Search interest for Aptevo Therapeutics Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 1, 2026 to August 31, 2026

Change:14% versus previous 30 day period

Aptevo Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	0	-
Gross Profit	0	0	0	0	0	0	-	0	0
Operating Income	-6	-6	-5	-6	-6	-6	-7	-5	-6
EBITDA	-6	-5	-5	-6	-6	-6	-7	-5	-6
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-5	-5	-6	-6	-6	-7	-5	-6
Income Tax Expense	0	0	-	-	-	-	-	-	-
Net Income	-6	-5	-5	-6	-6	-6	-7	-5	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2639.09%	0.00%

Aptevo Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	36	14	23	32	4	12	3	-	-	-
Gross Profit	12	9	11	-2	-13	12	3	0	0	0
Operating Income	-126	-53	-51	-40	-27	-21	-28	-28	-24	-26
EBITDA	-64	-48	-49	-40	-26	-20	7	-18	-23	-25
Interest Expense	-	-	-	-	-	7	35	-	-	-
Depreciation	-	3	2	2	1	1	0	0	0	0
Income Before Tax	-127	-55	-53	-43	-30	-29	7	-18	-24	-25
Income Tax Expense	-15	-23	-23	-2	-12	-2	-35	-1	-	-
Net Income	-112	6	-53	-44	-17	-27	8	-17	-24	-25
Net Profit Margin	-308.54%	47.57%	-232.75%	-137.85%	-411.93%	-222.20%	257.77%	0.00%	0.00%	0.00%

Aptevo Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-5	-5	-6	-6	-6	-7	-5	-6	-6
Operating Cash Flow	-6	-5	-5	-6	-7	-6	-5	-7	-5
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	3	4	6	-	14	18	5	0	0
Change in Cash	-2	0	0	-6	7	11	0	-7	-4

Aptevo Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	6	-53	-40	-17	-28	8	-17	-24	-25
Operating Cash Flow	-41	-51	-42	-29	-21	-21	-11	-23	-25
Investing Cash Flow	29	72	4	28	0	0	-	-	-
Financing Cash Flow	9	0	20	23	26	-2	5	15	38
Change in Cash	-2	20	-18	22	3	-23	-5	-8	12

Mutual Funds that own Aptevo Therapeutics Stock

Check out the Mutual Funds with significant holdings in Aptevo Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	0.705505%	12713
Fidelity Concord Street Trust	0.535136%	9643

Global Institutional Holdings in Aptevo Therapeutics

Funds	Holdings
Vanguard	0.71%

Aptevo Therapeutics News & Key Events

Insights on Aptevo Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 22.0% return, outperforming this stock by 122.0%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 564.8%
NEGATIVE IMPACT
Price Dip
In the last 1 month, APVO stock has moved down by -42.5%

About Aptevo Therapeutics

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment malignant pleural mesothelioma, non-small cell lung, gastric/gastro-esophageal, head and neck squamous cell carcinoma, pancreatic, renal, ovarian, prostate, breast, cervical, colorectal, endometrial, and bladder cancers; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Organisation	Aptevo Therapeutics
Headquarters	2401 4th Avenue, Seattle, WA, United States, 98121
Industry	Biotechnology
CEO	Mr. Jeffrey G. Lamothe CA
E-voting on shares	Click here to vote

Key Management of Aptevo Therapeutics

Name	Title
Mr. Marvin L. White	Executive Chair
Mr. Jeffrey G. Lamothe CA	CEO, President & Director
Ms. SoYoung Kwon J.D., LL.M.	Corporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs
Ms. Mary J. Janatpour Ph.D.	Senior VP & Chief Scientific Officer
Ms. Miriam Weber Miller	Vice President of Investor Relations & Corporate Communications
Dr. Dirk Huebner M.D.	Senior Vice President & Chief Medical Officer

FAQs

What is Aptevo Therapeutics share price today?

Aptevo Therapeutics share price today is $2.37 as on August 31, 2026 at 8:46 am IST at the close of the market. Aptevo Therapeutics share today touched a day high of $2.46 and a low of $2.31.

What is the 52 week high and 52 week low for Aptevo Therapeutics share?

Aptevo Therapeutics share touched a 52 week high of $48.78 on September 16, 2025 and a 52 week low of $2.30 on August 25, 2026. Aptevo Therapeutics stock price today i.e. August 31, 2026 at 8:46 am IST is closed at $2.37,which is 95.14% down from its 52 week high and 3.02% up from its 52 week low.

What is Aptevo Therapeutics's market capitalisation today?

Aptevo Therapeutics market capitalisation is $0.00T as on August 31, 2026 at 8:46 am IST.

How to invest in Aptevo Therapeutics Stock (APVO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aptevo Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aptevo Therapeutics Shares that will get you 0.6329 shares as per Aptevo Therapeutics share price of $2.37 per share as on August 31, 2026 at 8:46 am IST.

What is the minimum amount required to buy Aptevo Therapeutics Stock (APVO) from India?

Indian investors can start investing in Aptevo Therapeutics (APVO) shares with as little as ₹95.38 or $1 (as of August 31, 2026 at 3:49 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Aptevo Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2026 at 3:49 pm IST). Based on Aptevo Therapeutics share’s latest price of $2.37 as on August 31, 2026 at 8:46 am IST, you will get 4.2194 shares of Aptevo Therapeutics. Learn more about fractional shares .

What are the returns that Aptevo Therapeutics has given to Indian investors in the last 5 years?

Aptevo Therapeutics stock has given -100% share price returns and 30.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?